Cargando…

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis

BACKGROUND: Bevacizumab (Bev) plays the central role of the adjuvant therapy for patients with ovarian carcinoma. The aim of our study was to examine whether differences in the administration of Bev influence the prognosis of patients. METHODS: Patients with ovarian carcinoma who received treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suminokura, Jin, Miyamoto, Morikazu, Yoshikawa, Tomoyuki, Kouta, Hiroko, Kikuchi, Yoshihiro, Hada, Taira, Ishibashi, Hiroki, Ito, Tsubasa, Iwahashi, Hideki, Kakimoto, Soichiro, Suzuki, Rie, Matsuura, Hiroko, Kishimoto, Naohisa, Takano, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849038/ https://www.ncbi.nlm.nih.gov/pubmed/35172766 http://dx.doi.org/10.1186/s12885-022-09271-3

Ejemplares similares

Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
por: Iwahashi, Hideki, et al.
Publicado: (2022)

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
por: Kakimoto, Soichiro, et al.
Publicado: (2021)

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
por: Hada, Taira, et al.
Publicado: (2022)

Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature
por: Hada, Taira, et al.
Publicado: (2021)

Applicability of ultrasonography for detection of marginal sinus placenta previa
por: Ishibashi, Hiroki, et al.
Publicado: (2021)

Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
por: Hada, Taira, et al.
Publicado: (2021)

Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers
por: Yoshikawa, Tomoyuki, et al.
Publicado: (2021)

Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis
por: Hada, Taira, et al.
Publicado: (2023)

Clinical significance of retained products of conception in placenta previa: a retrospective analysis
por: Kishimoto, Naohisa, et al.
Publicado: (2023)

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
por: Miyamoto, Morikazu, et al.
Publicado: (2018)

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
por: Miyamoto, Morikazu, et al.
Publicado: (2017)

Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa
por: Soyama, Hiroaki, et al.
Publicado: (2016)

Successful Treatment with Pemetrexed, Carboplatin, and Bevacizumab for Platinum-Resistant Adenocarcinoma of the Lung
por: Wada, Sae, et al.
Publicado: (2012)

Resuscitative efficacy of hemoglobin vesicles for severe postpartum hemorrhage in pregnant rabbits
por: Ishibashi, Hiroki, et al.
Publicado: (2021)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Long-term survival of a patient with uterine cancer-induced pulmonary tumor thrombotic microangiopathy following treatment with platinum-based chemotherapy and bevacizumab: A case report
por: Taniguchi, Jumpei, et al.
Publicado: (2021)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
Publicado: (2014)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review
por: Miyamoto, Morikazu, et al.
Publicado: (2013)

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
por: Kato, Masafumi, et al.
Publicado: (2015)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
por: Suga, Takayoshi, et al.
Publicado: (2023)

Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
por: McClung, E Clair, et al.
Publicado: (2016)

Formation of 7-carboxyheptyl radical induced by singlet oxygen in the reaction mixture of oleic acid, riboflavin and ferrous ion under the UVA irradiation
por: Mori, Hiroko, et al.
Publicado: (2011)

Antioxidant Activity of Caffeic Acid through a Novel Mechanism under UVA Irradiation
por: Mori, Hiroko, et al.
Publicado: (2009)

Identification of the radicals formed in the reactions of some endogenous photosensitizers with oleic acid under the UVA irradiation
por: Mori, Hiroko, et al.
Publicado: (2012)

Lymphoscintigraphy with single-photon emission computerized tomography/computed tomography for evaluating lymphatic leakage following pelvic and para-aortic lymphadenectomy
por: Tsuchiya, Masato, et al.
Publicado: (2023)

Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages
por: Kono-Sato, Takako, et al.
Publicado: (2022)

Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
por: Ball, Graeme, et al.
Publicado: (2017)

Bevacizumab combined with chemotherapy in platinum-resistant ovarian cancer: beyond the AURELIA trial
por: Lyon, Kristopher A., et al.
Publicado: (2020)

Antioxidant Capacity of Tempura Deep-Fried Products Prepared Using Barley, Buckwheat, and Job’s Tears Flours
por: Taniguchi, Asuka, et al.
Publicado: (2020)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
por: Zamorano, Abigail S., et al.
Publicado: (2017)

Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
por: Sun, Li, et al.
Publicado: (2022)

Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer
por: Kotaka, Saki, et al.
Publicado: (2023)

Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer
por: Liu, Ying, et al.
Publicado: (2015)

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
por: Sostelly, Alexandre, et al.
Publicado: (2019)

REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer
por: Lavacchi, Daniele, et al.
Publicado: (2020)

The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion
por: Shen, Bairu, et al.
Publicado: (2022)

Retracted: Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis
por: Azemoto, Nobuaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4vtfdsspb3vjlftc2enm7lmr26